Año: 2023
Journal Impact Factor (JIF): 3.40
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| ONCOLOGY | ESCI | 110/322 | Q2 | T2 | D4 |
| BIOCHEMISTRY & MOLECULAR BIOLOGY | ESCI | 139/313 | Q2 | T2 | D5 |
Año: 2023
Journal Citation Indicator (JCI): 0,720
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| BIOCHEMISTRY & MOLECULAR BIOLOGY | 131/313 | Q2 | T2 | D5 | 58,31 |
| ONCOLOGY | 139/322 | Q2 | T2 | D5 | 56,99 |
Año:
2023
CiteScore:
6,900
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Oncology | 100/404 | Q1 | T1 | D3 |
| Cancer Research | 86/230 | Q2 | T2 | D4 |
SJR año:
2023
Factor de Impacto:
2,127
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cancer Research | 44/233 | Q1 | T1 | D2 |
| Oncology | 51/397 | Q1 | T1 | D2 |
| Agencia | Código de Proyecto |
|---|---|
| Association Espoir Isere Contre Le Cancer | - |
| Association GEFLUC Grenoble | - |
| Centre National de la Recherche Scientifique (CNRS) | - |
| Comites Departementaux Allier, Isere and Savoie de la Ligue Nationale contre le Cancer | - |
| ERICAN program of Fondation MSDAVENIR - Canceropole CLARA | DS-2018-0015 |
| Fondation ARC | PJA 2014-1201788; 00119148 |
| Fondation pour la Recherche Medicale | FDT202404018232 |
| Fondation pour la Recherche Medicale (FRM) | DEQ20170839117 |
| INCa-PLBIO | 2016155 |
| Inserm | - |
| Institut National de la Sante et de la Recherche Medicale (Inserm) | - |
| Institut National du Cancer (INCa) | INCA_16730; INCA_19472 |
| Institut National du Cancer (INCa) [INCa-PLBIO/Canceropole Ile de France] | PLBIO-2014-08; INCA_16730 |
| Ligue Nationale Contre le Cancer | IP/SC/SK-17250 |
| MSCA-IF-2017 (DNACHECK) | - |
| Region Auvergne-Rhpne-Alpes | - |
| Regional government of Andalucia (Junta de Andalucia) | - |
| Spanish Ministry of Science and Innovation-Agencia Estatal de Investigacion | PID2019-104195G |
| Univ. Grenoble Alpes | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Khalife, M | CNRS - National Institute for Biology (INSB) (France) |
| 2 | Jia, T | CNRS - National Institute for Biology (INSB); Sichuan University Key Laboratory of Drug Targeting and Drug Delivery System; Sichuan University West China School of Pharmacy (Peoples R China) |
| 3 | Caron, P | CNRS - National Institute for Biology (INSB) (France) |
| 4 | Shreim, A | CNRS - National Institute for Biology (INSB) (France) |
| 5 | Genoux, A | CNRS - National Institute for Biology (INSB) (France) |
| 6 | Cristini, A | Sin datos () |
| 7 | Pucciarelli, A | CNRS - National Institute for Biology (INSB) (France) |
| 8 | Leverve, M | CNRS - National Institute for Biology (INSB) (France) |
| 9 | Lepeltier, N | CNRS - National Institute for Biology (INSB) (France) |
| 10 | García-Rodríguez, N | University of Seville Faculty of Biology (Spain) |
| 11 | Dalonneau, F | CNRS - National Institute for Biology (INSB) (France) |
| 12 | Ramachandran, S | CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); University of Oxford Department of Oncology (Spain) |
| 13 | Martinez, LF | Universite Toulouse III - Paul Sabatier (France) |
| 14 | Marcion, G | Sin datos () |
| 15 | Lemaitre, N | Sin datos () |
| 16 | Brambilla, E | Universite Grenoble Alpes (UGA) (France) |
| 17 | Garrido, C | Institut National de la Sante et de la Recherche Medicale (Inserm) (France) |
| 18 | Hammond, EM | Sin datos () |
| 19 | Huertas, P | University of Seville Faculty of Biology (Spain) |
| 20 | Gazzeri, S | CNRS - National Institute for Biology (INSB) (France) |
| 21 | Sordet, O | Sin datos () |
| 22 | CNRS - National Institute for Biology (INSB) (France) |
